Last reviewed · How we verify
NCT05341791: CONSENT
Paper Versus Cartoon Video-based Administration of Study Information Notice for Participant Consent
NA trial testing Cartoon video describing study information notice in Information Disclosure in 350 participants. Completed in 30 October 2022.
30 June 2022
Quick facts
| Lead sponsor | Elizabeth Glaser Pediatric AIDS Foundation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 350 |
| Start date | 28 March 2022 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 October 2022 |
| Sites | 1 location across Cameroon |
Drugs / interventions tested
- Cartoon video describing study information notice
Conditions studied
- Information Disclosure — all drugs for Information Disclosure →
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Who can join
15 and older, any sex, with Information Disclosure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized trial in which participants are assigned to one of 2 strategies of information notice administration which include the standard approach versus a video-based cartoon approach. An information notice about the study will be administered to each participant individually. The study involves the integration of tuberculosis screening at all pediatric entry points, and other activities aimed at improving pediatric tuberculosis diagnosis and management. The understanding of participants will be assessed using a test of understanding adapted from the Quality of Informed consent (QIC).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05341791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Elizabeth Glaser Pediatric AIDS Foundation trials
Trials by the same sponsor.
- NCT05684887 — Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon · NA · completed
- NCT05529771 — Clinical Outcomes of paTients pREsenting to HArare COVID-19 CenTer of Excellence With SARS-CoV-2 Infection · completed
- NCT05458557 — Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2 · completed
- NCT05382130 — INTEGrating Ag-RDTs for COVID-19 in MNCH,HIV and TB Services in Cameroon and Kenya · NA · completed
- NCT05498727 — Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05341791 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elizabeth Glaser Pediatric AIDS Foundation
- Last refreshed: 16 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing